ST Pharm Co., a Korean pharmaceutical company. announced on Oct. 23 that its candidate for HIV treatment, "STP03-0404," has been selected as a life science project supported by the National Institute of Health (NIH) of the United States.ST Pharm Co. is an affiliate of Dong-A Socio Holdings, a holdin